Neurotensin (8-13) is an active fragment of Neurotensin,. Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density.
CAT No: R1550
CAS No: 60482-95-3
Synonyms/Alias: Neurotensin(8-13);60482-95-3;neurotensin (8-13);L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine;CHEMBL415788;(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid;Neurotensin (8-13) H-Arg-Arg-Pro-Tyr-Ile-Leu-OH;NT(8-13);Neurotensin (8-13) acetate salt;neurotensin-(8-13);GTPL7363;HY-P0251;BDBM50048908;AKOS037649204;BS-17187;DA-76141;FN108541;D80643;H-Arg-Arg-Pro-Tyr-Ile-Leu-OH; H-RRPYIL-OH;L-Leucine,L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C38H64N12O8 |
M.W/Mr. | 817 |
Sequence | One Letter Code:RRPYIL Three Letter Code:H-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
Purity | >97% (by HPLC) |
Shipping Condition | Shipped at room temperature |
InChI | InChI=1S/C38H64N12O8/c1-5-22(4)30(34(55)48-28(36(57)58)19-21(2)3)49-32(53)27(20-23-12-14-24(51)15-13-23)47-33(54)29-11-8-18-50(29)35(56)26(10-7-17-45-38(42)43)46-31(52)25(39)9-6-16-44-37(40)41/h12-15,21-22,25-30,51H,5-11,16-20,39H2,1-4H3,(H,46,52)(H,47,54)(H,48,55)(H,49,53)(H,57,58)(H4,40,41,44)(H4,42,43,45)/t22-,25-,26-,27-,28-,29-,30-/m0/s1 |
InChI Key | DQDBCHHEIKQPJD-ODKJCKIQSA-N |
Canonical SMILES | CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N |
Isomeric SMILES | CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N |
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.